| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2019 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VAXCYTE INC | 15 | Q2 2024 | 46.0% |
| INOZYME PHARMA INC | 15 | Q2 2024 | 22.1% |
| ARCUTIS BIOTHERAPEUTICS INC | 15 | Q2 2024 | 14.6% |
| ALIGOS THERAPEUTICS INC | 15 | Q2 2024 | 8.0% |
| BOLT BIOTHERAPEUTICS INC | 14 | Q2 2024 | 20.0% |
| FUSION PHARMACEUTICALS INC | 14 | Q1 2024 | 7.7% |
| KARUNA THERAPEUTICS INC | 13 | Q4 2023 | 65.4% |
| RALLYBIO CORP | 12 | Q2 2024 | 14.1% |
| EXSCIENTIA PLC | 11 | Q2 2024 | 6.4% |
| VIGIL NEUROSCIENCE INC | 10 | Q2 2024 | 3.0% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.